unknown
Stage
2
Investors
About
EpilepsyGTx is a late preclinical-stage biotech developing gene therapies to provide seizure freedom for patients with focal refractory epilepsy.
Explore Epilepsy GTX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.